OR WAIT null SECS
July 22, 2010
Pfizer Ends Second Tanezumab Clinical Program; Catalent VP Joins USP Panel; And More.
July 15, 2010
Xcelience and Penn Form Joint Venture; Almac Appoints QA Director; And More.
July 08, 2010
Eli Lilly to Acquire Alnara Pharmaceuticals; Exelixis CEO Leaves for Biogen Idec; And More.
July 02, 2010
To continue innovating, the biopharmaceutical sector needs support from all levels.
The functionality and performance of three types of commercial superdisintegrants were evaluated in the application of orally disintegrating tablets.
Is now the time for multiparticulates to shine as a controlled-release solution?
Technical Note: The authors investigated the variables important for calcium-alginate formation as well as dissolution.
Excipient manufacturers expand their products, services, manufacturing capacity, and technology positions.
After a spate of industrial disasters, the public seeks greater oversight of corporations-so does FDA.
July 01, 2010
Pfizer Suspends Tanezumab Program; Actavis Appoints CEO; And More.